Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Critical Care (London, England)|November 20, 2024
A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) studySubhash Todi, Yatin Mehta, Kapil Zirpe, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|March 10, 2023
Competencies for Point-of-care Ultrasonography in ICU: An ISCCM Expert Panel Practice RecommendationShrikanth Srinivasan, Praveen G Kumar, Deepak Govil, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|December 17, 2021
Intensive Care in India in 2018-2019: The Second Indian Intensive Care Case Mix and Practice Patterns StudyJigeeshu V Divatia, Yatin Mehta, Deepak Govil, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|September 14, 2019
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised PatientsAtul P Kulkarni, Manju Sengar, Girish Chinnaswamy, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|January 30, 2025
Salt Based or BaLanced SolUtion-Trends Existing in Indian Intensive Care Units: A Multicenter Prospective Observational Cohort Study (SOLUTE Study)Sachin Gupta, Subhal Dixit, Deeksha S Tomar, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|September 5, 2024
ISCCM Position Statement for Improving Gender Balance in Critical Care MedicinePrachee Sathe, Urvi Shukla, Farhad N Kapadia, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 4